88 related articles for article (PubMed ID: 25854120)
1. Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012.
Dinmohamed AG; Brink M; Visser O; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M; de Greef GE
Br J Haematol; 2015 Nov; 171(3):436-9. PubMed ID: 25854120
[No Abstract] [Full Text] [Related]
2. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
[TBL] [Abstract][Full Text] [Related]
3. Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a registry-based study.
Durairaj S; Keenan N; Hyslop A; Groves MJ; Bowen DT; Tauro S
Br J Haematol; 2013 Apr; 161(2):280-2. PubMed ID: 23294041
[No Abstract] [Full Text] [Related]
4. Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
Faber E; Mužík J; Koza V; Demečková E; Voglová J; Demitrovičová L; Chudej J; Markuljak I; Cmunt E; Kozák T; Tóthová E; Jarošová M; Dušek L; Indrák K
Eur J Haematol; 2011 Aug; 87(2):157-68. PubMed ID: 21535160
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of chronic myeloid leukaemia patients with p210 and p190 co-expression at baseline.
Molica M; Zacheo I; Diverio D; Alimena G; Breccia M
Br J Haematol; 2015 Apr; 169(1):148-50. PubMed ID: 25296902
[No Abstract] [Full Text] [Related]
6. Prolonged survival in chronic granulocytic leukaemia.
Kalra OP; Prakash C; Mittal R; Verma SC; Mohanty D
J Assoc Physicians India; 1988 May; 36(5):352-3. PubMed ID: 3053635
[No Abstract] [Full Text] [Related]
7. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Vallapureddy R; Lasho TL; Hoversten K; Finke CM; Ketterling R; Hanson C; Gangat N; Tefferi A; Patnaik MM
Am J Hematol; 2017 Oct; 92(10):E614-E618. PubMed ID: 28707414
[No Abstract] [Full Text] [Related]
9. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
[TBL] [Abstract][Full Text] [Related]
10. Treatment choices in chronic myelogenous leukemia.
Ready N; Freeman NJ; Carvalho A
Hosp Pract (Off Ed); 1992 Sep; 27(9A):95-8, 101. PubMed ID: 1522171
[No Abstract] [Full Text] [Related]
11. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.
De Matteis G; Veneri D; Aprili F; Benati M; Paviati E; Guidi GC; Pizzolo G; Tecchio C
Ann Hematol; 2013 Mar; 92(3):413-5. PubMed ID: 23053185
[No Abstract] [Full Text] [Related]
12. [Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].
Hochhaus A; Hehlmann R
Internist (Berl); 1996 Oct; 37(10):1013-21. PubMed ID: 9019445
[No Abstract] [Full Text] [Related]
13. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
Griesshammer M; Heimpel H
Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
[No Abstract] [Full Text] [Related]
14. Identification of risk factors in atypical chronic myeloid leukemia.
Breccia M; Biondo F; Latagliata R; Carmosino I; Mandelli F; Alimena G
Haematologica; 2006 Nov; 91(11):1566-8. PubMed ID: 17043019
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.
Giona F; Putti MC; Micalizzi C; Menna G; Moleti ML; Santoro N; Iaria G; Ladogana S; Burnelli R; Consarino C; Varotto S; Tucci F; Messina C; Nanni M; Diverio D; Biondi A; Pession A; Locatelli F; Piciocchi A; Gottardi E; Saglio G; Foà R
Br J Haematol; 2015 Aug; 170(3):398-407. PubMed ID: 25891192
[TBL] [Abstract][Full Text] [Related]
16. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.
Brunner AM; Campigotto F; Sadrzadeh H; Drapkin BJ; Chen YB; Neuberg DS; Fathi AT
Cancer; 2013 Jul; 119(14):2620-9. PubMed ID: 23625575
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
[TBL] [Abstract][Full Text] [Related]
18. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and therapy in chronic myeloid leukaemia.
Mehta J; Singhal S; Mehta BC
J Assoc Physicians India; 1992 Feb; 40(2):130-1. PubMed ID: 1629126
[No Abstract] [Full Text] [Related]
20. The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia.
Larfors G; Sandin F; Richter J; Själander A; Stenke L; Lambe M; Höglund M
Eur J Haematol; 2017 Apr; 98(4):398-406. PubMed ID: 28009456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
